Independent Wealth Network Inc. Acquires 287 Shares of The Clorox Company (NYSE:CLX)

Independent Wealth Network Inc. grew its holdings in shares of The Clorox Company (NYSE:CLX) by 7.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,264 shares of the company’s stock after acquiring an additional 287 shares during the quarter. Independent Wealth Network Inc.’s holdings in Clorox were worth $692,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. Brooklyn Investment Group increased its stake in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new position in shares of Clorox in the third quarter valued at approximately $27,000. Continuum Advisory LLC increased its stake in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares during the period. Quarry LP increased its stake in shares of Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after buying an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC acquired a new position in shares of Clorox in the third quarter valued at approximately $48,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Down 0.7 %

Shares of Clorox stock opened at $158.91 on Thursday. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The firm has a market cap of $19.67 billion, a PE ratio of 55.37, a P/E/G ratio of 2.95 and a beta of 0.42. The stock has a fifty day moving average price of $164.06 and a 200-day moving average price of $157.10. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the firm posted $0.49 EPS. The business’s revenue was up 27.0% compared to the same quarter last year. Equities research analysts anticipate that The Clorox Company will post 6.87 EPS for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.07%. Clorox’s dividend payout ratio is currently 170.04%.

Analysts Set New Price Targets

Several analysts recently commented on CLX shares. Evercore ISI reduced their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Wells Fargo & Company upgraded Clorox from an “underweight” rating to an “equal weight” rating and increased their price target for the stock from $155.00 to $157.00 in a report on Tuesday, January 7th. JPMorgan Chase & Co. increased their price target on Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a report on Thursday, January 16th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, Barclays cut their price target on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a report on Friday, January 17th. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $156.54.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.